Elevance Health Inc.
Elevance Health Inc. (ELV) Stock Overview
Explore Elevance Health Inc.’s financial performance, market position, analyst ratings, and future outlook.
ELV Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Elevance Health Inc. (ELV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $433.39.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.87 and a market capitalization of 87.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Gail Koziara Boudreaux
104,200
220 Virginia Avenue, Indianapolis, IN
2001